Trial Supports GLP-1 After Underwhelming Metabolic Surgery

(MedPage Today) -- Adding a GLP-1 receptor agonist to lifestyle intervention helped to bolster weight loss in patients with poor outcomes following primary metabolic surgery, the BARI-OPTIMISE randomized trial found. Looking at 70 individuals...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news